⚠️ Heads up: This is info only. Not investment advice. Don’t buy or sell anything based on a blog post.
TL;DR: Isomorphic Labs — the DeepMind spinoff — raised $2.1 billion to find drugs with AI. Wandercraft got $75M for medical exoskeletons in France. Neura Robotics hit a €1 billion valuation in Germany. In public markets, Tesla and NVIDIA rose on humanoid optimism, but Palantir dropped 4.4%. A-share robotics names were broadly down.
Private Markets — Who Got Money
Isomorphic Labs — $2.1B Series B | AI Drug Discovery
What they do: Use AlphaFold — the protein structure prediction system that won a Nobel Prize — to design actual drugs internally. Not just model proteins for academics. Real drug discovery.
Who put money in: Thrive Capital led. This is one of the largest single raises in AI life sciences ever.
Why it matters: Demis Hassabis now runs both frontier AI research (DeepMind) and billion-dollar commercial drug discovery (Isomorphic) at the same time. Biotech is becoming the highest-value AI market outside consumer software.
My take: $2.1B is not a venture round. It’s infrastructure funding. Isomorphic is building a platform, not a single drug. If it works, this could change how all drugs are discovered.
Credibility: 🔴 Company announced
Wandercraft — $75M Series D | Medical Exoskeletons
What they do: Build medical-grade self-balancing exoskeletons — Atalante and a next-gen Personal Exoskeleton. Now extending into AI-powered humanoid robotics.
Who put money in: Renault Group and Bpifrance-managed PSIM co-led. Total funding now over $200M.
Why it matters: This is the European robotics template — medical certification first (CE marking, ISO 13485), then industrial expansion. France’s France 2030 plan earmarked €7.5B for AI and robotics. Wandercraft is drawing from that well.
Credibility: 🔴 Company announced
Neura Robotics — €120M Series B | Cognitive Industrial Robots
What they do: Ship MAiRA, a cognitive industrial robot, and 4NE-1, a humanoid platform for German manufacturing.
Who put money in: Lingotto Investment Management led. HV Capital and Volvo Cars Tech Fund joined. Valuation: over €1 billion.
Why it matters: Neura had paying industrial pilots with German Mittelstand customers before the raise. That’s the German playbook: prove it works, then raise. Volvo’s strategic investment signals automotive OEM interest in next-gen assembly.
Credibility: 🔴 Company announced
Vbot — $73M Pre-A | Robotic Dogs + Humanoids
What they do: Embodied AI startup shipping robotic dogs now, planning humanoids next.
Who put money in: Oriental Fortune Capital, Huatai Zijin Investment, Fosun RZ Capital co-led. SAIC Motor’s Shangqi Capital joined.
Why it matters: Vbot is already shipping — 500 robotic dog units now, scaling to 2,500 per month by June. That’s revenue, not just a pitch deck. The robotic dog is a smart stepping stone to humanoids.
Credibility: 🟡 Reported by PanDaily
Public Markets — How Stocks Moved
Note: A-share data from current session. US and HK from last session.
| Company | Ticker | Price | Change | Why It Moved |
|---|---|---|---|---|
| NVIDIA | NVDA | $225.83 | +2.29% | Humanoid/robotics platform optimism |
| Tesla | TSLA | $445.27 | +2.73% | Optimus humanoid sentiment |
| Intuitive Surgical | ISRG | $432.27 | +0.09% | Flat, stable surgical demand |
| Teradyne | TER | $363.38 | +1.38% | Test equipment demand |
| Symbotic | SYM | $49.73 | -3.10% | Warehouse automation pullback |
| Palantir | PLTR | $130.05 | -4.38% | Profit-taking after recent rally |
| UBTECH | 9880.HK | HK$109.30 | -3.10% | Profit-taking after recent rally |
| Xiaomi | 1810.HK | HK$32.22 | +1.32% | Ecosystem growth |
| AAC Tech | 2018.HK | HK$44.38 | +1.79% | Sensor components demand |
| Lenovo | 0981.HK | HK$73.25 | -1.21% | Minor drift |
A-Share Robotics (12 stocks)
| Ticker | Company | Price | Change |
|---|---|---|---|
| 688017.SH | Leader Harmonious Drive Systems | ¥274.35 | -1.90% |
| 002747.SZ | Estun Automation | ¥23.86 | -1.40% |
| 300124.SZ | Inovance Technology | ¥75.43 | -1.35% |
| 688256.SH | Cambricon | ¥1,270.22 | -3.54% |
| 002236.SZ | Dahua Technology | ¥17.96 | -2.02% |
| 002472.SZ | Shuanghuan Transmission | ¥41.40 | -1.97% |
| 002050.SZ | Sanhua Intelligent Controls | ¥50.74 | -1.48% |
| 003021.SZ | Zhaowei Machinery | ¥100.89 | -1.32% |
| 601127.SH | Seres Group | ¥86.05 | -1.61% |
| 688169.SH | Roborock | ¥117.18 | -2.35% |
| 300024.SZ | SIASUN Robot | ¥15.05 | -2.27% |
| 688322.SH | Orbbec | ¥85.55 | -2.40% |
A-share note: Broadly down today. Cambricon led decliners at -3.54%. Only Zhaowei Machinery was relatively flat at -1.32%. Sector rotation or profit-taking after recent robotics hype.
🔮 What’s Next
| Signal | Odds | Time | Impact |
|---|---|---|---|
| Isomorphic Labs announces first AI-designed drug candidate | 60% | 6-12 months | Would validate $2.1B platform |
| Wandercraft expands into humanoid robotics | 70% | 12-18 months | Medical → industrial crossover |
| Neura Robotics lands automotive OEM contract | 50% | 3-6 months | Volvo connection is the signal |
| Vbot hits 2,500 units/month production | 80% | 4-6 weeks | Operational milestone |
| A-share robotics sector rebounds | 50% | 1-2 weeks | Depends on broader market sentiment |
Daily Snapshot
| Metric | Figure |
|---|---|
| Mega-rounds ($1B+) | 1 (Isomorphic Labs $2.1B) |
| Series D / B rounds | 2 (Wandercraft $75M, Neura €120M) |
| Pre-A rounds | 1 (Vbot $73M) |
| Public market top gainer | TSLA +2.73% |
| Public market top decliner | PLTR -4.38% |
| A-share decliners | 12 / 12 down |
🔥 Market Take
Private: The money is moving into applied AI — drug discovery (Isomorphic), medical devices (Wandercraft), industrial robots (Neura), and consumer hardware (Vbot). This is not model research funding. This is deployment capital.
Public: US robotics names (NVDA, TSLA) are up on humanoid optimism. A-share is down across the board — profit-taking after weeks of hype. The divergence suggests US investors are betting on the platform (NVIDIA, Tesla) while Chinese investors are taking profits in the supply chain (Cambricon, Leader Harmonious).
For informational purposes only. Not investment advice.